Access to local regulators and payers

Despite a growing trend towards regional harmonisation, specific local requirements remain highly significant and need to be carefully considered as a core function of global strategy.

Our competence, expertise in different regions and  privileged relationships with local health authorities and key opinion leaders facilitate formal and informal dialogue between industry, regulatory agencies and payers.

We bridge your regulatory needs between Europe and US


Microbiome Replay

Watch our latest webinar to get tips on the regulatory and CMC technical for microbiome development.

Watch it


Learn about regulatory frameworks and incentives associated with orphan drug designation (ODD) in the EU and the US